Siga Technologies (SIGA) Cash from Investing Activities (2010 - 2025)
Siga Technologies (SIGA) reported Cash from Investing Activities of -$289576.0 for Q3 2025, down 1191.19% on a YoY basis from $26537.5 in Q3 2024, and down 28957500.0% quarter-over-quarter from -$1.0 in Q2 2025.
Siga Technologies (SIGA) Cash from Investing Activities (2010 - 2025) Analysis & Trends
Siga Technologies has reported Cash from Investing Activities for 15 years, with the latest figure at -$289576.0 in Q3 2025.
- For the quarter ending Q3 2025, Cash from Investing Activities fell 1191.19% year-over-year to -$289576.0; the trailing twelve-month figure through Sep 2025 stood at -$332308.0 (down 1250.19% YoY), and the FY2024 full-year result was -$42450.0, down 95.75% from the prior year.
- Cash from Investing Activities for Q3 2025 stood at -$289576.0, down from -$1.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was -$1.0 in Q2 2025, with the low at -$289576.0 in Q3 2025.
- Historically, Cash from Investing Activities has averaged -$42922.6 across 4 years, with a median of -$19762.0 in 2023.
- The largest YoY upside for Cash from Investing Activities was 99.95% in 2025 against a maximum downside of 1191.19% in 2025.
- Siga Technologies' Cash from Investing Activities stood at -$26196.0 in 2021, then gained by 17.22% to -$21686.0 in 2023, then climbed by 17.74% to -$17838.0 in 2024, then slumped by 1523.37% to -$289576.0 in 2025.
- The last three Cash from Investing Activities figures came in at -$289576.0 (Q3 2025), -$1.0 (Q2 2025), and -$24893.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.45 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 25.99 Mn |
| 10 | Siga Technologies | 314.73 Mn | 159.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -289,576.00 |
| Sep 30, 2025 | -289,576.00 |
| Jun 30, 2025 | -1.00 |
| Jun 30, 2025 | -1.00 |
| Mar 31, 2025 | -24,893.00 |
| Mar 31, 2025 | -24,893.00 |
| Dec 31, 2024 | -17,838.00 |
| Dec 31, 2024 | -17,838.00 |
| Sep 30, 2024 | -22,427.00 |
| Sep 30, 2024 | -22,427.00 |
| Jun 30, 2024 | -2,185.00 |
| Jun 30, 2024 | -2,185.00 |
| Jun 30, 2023 | -21,686.00 |
| Jun 30, 2023 | -21,686.00 |
| Dec 31, 2021 | -26,196.00 |
| Dec 31, 2021 | -26,196.00 |
| Jun 30, 2021 | -10,700.00 |
| Jun 30, 2021 | -10,700.00 |
| Mar 31, 2021 | -13,724.00 |
| Mar 31, 2021 | -13,724.00 |